The Novo-backed biotechnology company has filed for an $86.3m initial public offering, after raising $89m in funding since 2005.

The cancer treatment developer has raised $165m in venture capital from investors including pharmaceutical companies Roche and Pfizer.

The Naver-owned messaging service, which initially planned to float last year, has suspended its plans to go public again.

The cancer treatment developer has raised $94m in equity and grant funding, with Pfizer, Celgene and Baxter among its shareholders.

The cancer treatment developer has raised $94m in equity and grant funding, with Pfizer, Celgene and Baxter among its shareholders.

General electric-backed genomics tool developer RainDance Technologies has called off its initial public offering after raising more than $100m in equity.

Gene therapy developer RegenXBio, backed by investors including GlaxoSmithKline, has so far raised more than $110m in venture funding.

The Delta Electronics-backed company, which has developed an artificial heart for transplants, has filed for a $40m initial public offering on Nasdaq.

The ProSiebenSat.1 and Access Industries-backed music streaming service is considering another equity round or an initial public offering to raise more cash.

The Samsung-backed flash storage company was valued at $3bn as of its last funding round, a $225m series F round closed last year.